These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11816874)

  • 1. Lamotrigine in the treatment of depersonalization disorder.
    Sierra M; Phillips ML; Lambert MV; Senior C; David AS; Krystal JH
    J Clin Psychiatry; 2001 Oct; 62(10):826-7. PubMed ID: 11816874
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lamotrigine in the treatment of resistant depersonalization disorder: A case report].
    Bout A; Berhili N; Benbrahim M; Aalouane R; Rammouz I
    Encephale; 2018 Feb; 44(1):85-87. PubMed ID: 28602528
    [No Abstract]   [Full Text] [Related]  

  • 3. A placebo-controlled, cross-over trial of lamotrigine in depersonalization disorder.
    Sierra M; Phillips ML; Ivin G; Krystal J; David AS
    J Psychopharmacol; 2003 Mar; 17(1):103-5. PubMed ID: 12680746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of lamotrigine in a resistant case of depersonalization disorder.
    Rosagro-Escámez F; Gutiérrez-Fernández N; Gómez-Merino P; de la Vega I; Carrasco JL
    Actas Esp Psiquiatr; 2011; 39(4):263-6. PubMed ID: 21769750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lamotrigine as an add-on treatment for depersonalization disorder: a retrospective study of 32 cases.
    Sierra M; Baker D; Medford N; Lawrence E; Patel M; Phillips ML; David AS
    Clin Neuropharmacol; 2006; 29(5):253-8. PubMed ID: 16960469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lamotrigine in the immediate treatment of outpatients with depersonalization disorder without psychiatric comorbidity: randomized, double-blind, placebo-controlled study.
    Aliyev NA; Aliyev ZN
    J Clin Psychopharmacol; 2011 Feb; 31(1):61-5. PubMed ID: 21192145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depersonalization and derealization syndrome: report on a case study and pharmacological management.
    Salgado A; Oliveira L; Sierra-Siegert M; Salgado JV
    Braz J Psychiatry; 2012 Dec; 34(4):505-8. PubMed ID: 23429825
    [No Abstract]   [Full Text] [Related]  

  • 8. Lamotrigine as an augmentation agent in treatment-resistant depression.
    Barbee JG; Jamhour NJ
    J Clin Psychiatry; 2002 Aug; 63(8):737-41. PubMed ID: 12197456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lamotrigine treatment of refractory bipolar disorder.
    Fogelson DL; Sternbach H
    J Clin Psychiatry; 1997 Jun; 58(6):271-3. PubMed ID: 9228895
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term use of lamotrigine and vigabatrin in severe refractory epilepsy: audit of outcome.
    Walker MC; Li LM; Sander JW
    BMJ; 1996 Nov; 313(7066):1184-5. PubMed ID: 8916751
    [No Abstract]   [Full Text] [Related]  

  • 11. Lamotrigine administration in panic disorder with agoraphobia.
    Masdrakis VG; Papadimitriou GN; Oulis P
    Clin Neuropharmacol; 2010 May; 33(3):126-8. PubMed ID: 20502131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lamotrigine: clinical experience in 93 patients with epilepsy.
    Buchanan N
    Acta Neurol Scand; 1995 Jul; 92(1):28-32. PubMed ID: 7572057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delirium from valproic acid with lamotrigine.
    Mueller TH; Beeber AR
    Am J Psychiatry; 2004 Jun; 161(6):1128-9. PubMed ID: 15169707
    [No Abstract]   [Full Text] [Related]  

  • 14. Methylphenidate in depersonalization disorder: a case report.
    Foguet Q; Alvárez MJ; Castells E; Arrufat F
    Actas Esp Psiquiatr; 2011; 39(1):75-8. PubMed ID: 21274825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lamotrigine and partial epilepsy in children: a second-line option.
    Prescrire Int; 2003 Jun; 12(65):110. PubMed ID: 12825605
    [No Abstract]   [Full Text] [Related]  

  • 16. A 52-week, open-label continuation study of lamotrigine in the treatment of bipolar depression.
    McElroy SL; Zarate CA; Cookson J; Suppes T; Huffman RF; Greene P; Ascher J
    J Clin Psychiatry; 2004 Feb; 65(2):204-10. PubMed ID: 15003074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agranulocytosis associated with lamotrigine.
    Solvason HB
    Am J Psychiatry; 2000 Oct; 157(10):1704. PubMed ID: 11007735
    [No Abstract]   [Full Text] [Related]  

  • 18. Lamotrigine-induced rash after sun exposure.
    Bozikas V; Vartzopoulos D; Phocas C; Karavatos A; Kaprinis G
    Am J Psychiatry; 1999 Dec; 156(12):2015-6. PubMed ID: 10588424
    [No Abstract]   [Full Text] [Related]  

  • 19. Toxic epidermal necrolysis associated with concomitant use of lamotrigine and carbamazepine: a case report.
    Mansouri P; Rabiei M; Pourpak Z; Hallaji Z
    Arch Dermatol; 2005 Jun; 141(6):788-9. PubMed ID: 15967934
    [No Abstract]   [Full Text] [Related]  

  • 20. Association of lamotrigine and valproate in refractory epilepsies of children and adolescents.
    Grisotto KP; Bruck I; Antoniuk SA; Santos LH
    Arq Neuropsiquiatr; 2008 Sep; 66(3A):477-81. PubMed ID: 18813703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.